D-fluoromethyltyrosine F-18

DB15296InvestigationalSmall molecule

D-fluoromethyltyrosine F-18 is under investigation in clinical trial NCT01089998 (PET/CT Imaging for Radiation Dosimetry, Plasma Pharmacokinetics, Safety and Tolerability in Healthy Volunteers and Safety, Tolerability and Diagnostic Performance of BAY86-9596...

Formula / weight: C₁₀H₁₂FNO₃ · 212.211 g/mol (avg)
Code names: BAY86-9596

Resolves to

Compound

UNII58HVN5SR99CAS870452-26-9

Structure

InChIKeyGEBHVOHKNWLITQ-DEVVULMSSA-NSMILESN[C@H](CC1=CC=C(OC[18F])C=C1)C(O)=O

Transporters

Q01650SLC7A5

What you can answer from here — as of July 08, 2026

1TransporterSubstrate / inhibitor direction, not just membership

Listed above

1Clinical trialPhase, status and sponsor resolved per trial

1+ReferenceStructured and connected to the statements they support

Which companies are running trials of D-fluoromethyltyrosine F-18, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account